Current status of anaplastic thyroid carcinoma

Abrahams Ocanto1,2, Lisselott Torres1,3, Felipe Couñago1,3

  • 1Department of Radiation Oncology, San Francisco de Asís University Hospital, Genesis Care, Madrid 28002, Spain.

Summary

Anaplastic thyroid carcinoma (ATC) management is evolving. Surgery and radiotherapy remain key, with new molecularly targeted therapies and emerging immunotherapies showing promise for improved patient survival.